RDD Pharma Ltd

Industry · 11 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	RDD1609 as a Treatment for Idiopathic Pruritus Ani Idiopathic Pruritus Ani	Phase 2	2020-05-01
Unknown	Intra-anal Oxymetazoline in Healthy Adult Volunteers Fecal Incontinence	Phase 1	2018-08-20
Completed	The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fis Chronic Anal Fissure	Phase 2 / Phase 3	2016-05-01
Completed	The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients Fecal Incontinence, Spinal Cord Injury	Phase 1 / Phase 2	2014-11-01
Terminated	An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Anal Fissure	Phase 1 / Phase 2	2014-03-01
Withdrawn	A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence	Phase 1 / Phase 2	2011-08-01
Completed	An Study to Examine the Effect of Coated Suppositories on Anal Pressure in Healthy Subjects Fecal Incontinence	Phase 1 / Phase 2	2011-08-01
Withdrawn	A Double Blinded Study to Examine the Effect of Coated Suppositories on Fecal Incontinence in Patients With Sp Fecal Incontinenece	Phase 2	2011-04-01
Completed	An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Chronic Anal Fissure	Phase 1 / Phase 2	2009-12-01
Completed	Study to Examine the Effect of Coated Phenylephrine Suppositories on Anal Pressure in Healthy Subjects Incontinence	Phase 1 / Phase 2	2009-09-01
Completed	An Open Label Study to Examine the Effect of Coated Nifedipine Suppositories on Anal Pressure in Healthy Subje Anal Resting Pressure	Phase 1 / Phase 2	—